Skip to main content
Medical information Clinical review pending

Cytogenetics

PSA Prostate-Specific Antigen Free Test

The PSA Prostate-Specific Antigen Free Test helps assess prostate health and detect potential prostate cancer early. This blood test measures the level of free PSA.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. Confirm with the laboratory before booking.
Test priceKSh 1,989

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the PSA Prostate-Specific Antigen Free Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Screening for prostate cancer in men over 50.
  • ✓Men with a family history of prostate cancer.
  • ✓Men experiencing urinary symptoms like difficulty urinating or frequent urination.
  • ✓Monitoring prostate cancer after treatment.
  • ✓Evaluating elevated total PSA levels.
02

In plain language

What this test helps you understand

Assists in the early detection and monitoring of prostate cancer and other prostate conditions.
The PSA Prostate-Specific Antigen Free Test is a diagnostic tool used to evaluate prostate health and aid in the detection of prostate cancer. Prostate cancer is a common cancer among men, and early detection significantly improves treatment outcomes. This test measures the amount of prostate-specific antigen (PSA) in the blood, which can indicate prostate issues, including cancer.

This test specifically measures the 'free' form of PSA. Elevated levels can be associated with prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis. It is often used alongside other diagnostic methods for a complete prostate health assessment.

Men over 50, those with a family history of prostate cancer, or individuals experiencing urinary symptoms may benefit from this test. Symptoms that might prompt testing include difficulty urinating, frequent urination (especially at night), blood in urine or semen, or pain during urination or ejaculation.

Taking this test offers benefits such as early detection of prostate cancer, allowing for timely treatment, monitoring prostate health over time, and providing peace of mind.

Discuss your results with your doctor. While results are typically available within a day, interpretation requires medical expertise. Elevated levels may indicate the need for further evaluation.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. Confirm with the laboratory before booking.
SampleBlood sample.
MethodologyImmunoassay.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Elevated PSA levels can be caused by conditions other than cancer, such as BPH or prostatitis. Further investigation is often needed to determine the cause of elevated PSA.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The test measures the level of Prostate-Specific Antigen (PSA), a protein produced by the prostate gland, in your blood.
No, elevated PSA levels can be caused by various conditions, including benign prostatic hyperplasia (BPH), prostatitis, or recent ejaculation. Further evaluation is needed.
Men over 50, those with a family history of prostate cancer, or men experiencing urinary symptoms should discuss testing with their doctor.
The frequency of testing depends on your age, risk factors, and previous results. Consult your doctor for personalized recommendations.
If your results are abnormal, your doctor will discuss the findings with you and may recommend further tests or procedures.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp